Novartis expects to launch a clinical trial of swine flu vaccine this month Using both a traditional egg-based as well as a cell-based approach in developing a new vaccine for swine (H1N1) flu, pharma giant, Novartis says it expects to launch a clinical trial of a new jab … [Read more...] about H1N1 Vaccine Orders Pour Into Novartis